Medication info

Acetamadol Tablets

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
R.P. Bio Co., Ltd.
Appearance
Pale yellow oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201601861 · Approved 2016.03.23

This product's status changed to Approval withdrawn on 2025.02.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Tramadol is removed very slowly by hemodialysis and filtration; therefore, repeat administration of this medicine after dialysis is not necessary to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
R.P. Bio Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medicine is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Tramadol is removed very slowly by hemodialysis and filtration; therefore, repeat administration of this medicine after dialysis is not necessary to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medicine may put a burden on the liver, so it is essential that individuals who consume more than three alcoholic drinks daily consult with a doctor or pharmacist before taking it. If you experience unusual reactions such as skin rash or itching while taking this medicine, it is important to stop taking it immediately and notify your healthcare provider. This medicine carries a risk of seizures, so patients with a history of seizures or at high risk for seizures should use it cautiously. Patients with severe respiratory depression or asthma may experience worsened breathing issues while taking this medicine; therefore, special caution is needed. This medicine can affect the central nervous system, and taking it with alcohol or sedatives may increase the risk of drowsiness or respiratory depression, so co-administration should be avoided. Patients with head injuries or brain diseases should be cautious as taking this medicine may pose risks of elevated intracranial pressure or altered consciousness. This medicine may cause psychological and physical dependence, so careful monitoring of dependence is required with long-term use. Patients with impaired liver function should consult a physician before taking this medicine and be careful not to exceed the recommended dose. Children under 12 years old and adolescents under 18 who have undergone tonsillectomy and adenoidectomy should not take this medicine. Pregnant or breastfeeding women should consult a physician before taking this medicine as it may affect the fetus or newborn. This medicine may cause drowsiness or dizziness while driving or operating machinery, so caution is needed when engaging in such activities. In cases of overdose, serious side effects such as respiratory depression, seizures, or liver damage may occur, making it imperative to strictly adhere to the dosing regimen and visit a healthcare facility immediately if abnormal symptoms arise. This medicine should be stored out of reach of children to prevent accidental ingestion, and it should be kept secure to prevent unauthorized use by others.

Side effects

  • Liver damage
  • acute generalized eruptive pustulosis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • seizures
  • anaphylactic reaction
  • respiratory depression
  • deep sedation
  • coma
  • hepatotoxicity
Show 167 more
  • hyponatremia
  • decreased appetite
  • insomnia
  • depression
  • dizziness
  • headache
  • drowsiness
  • nausea
  • vomiting
  • constipation
  • dry mouth
  • diarrhea
  • dyspepsia
  • abdominal pain
  • abdominal discomfort
  • flatulence
  • pruritus
  • sweating
  • rash
  • fatigue
  • flushing
  • urticaria
  • hypersensitivity
  • hypoglycemia
  • anxiety
  • nervousness
  • emotional instability
  • euphoria
  • decreased libido
  • sleep disorders
  • confusion
  • disorientation
  • agitation
  • abnormal dreams
  • substance abuse
  • hallucinations
  • withdrawal syndrome
  • migraine
  • somnolence
  • sensory loss
  • tremor
  • paresthesia
  • attention deficit
  • syncope
  • memory impairment
  • psychomotor agitation
  • sedation
  • amnesia
  • perceptual disturbances
  • convulsions
  • blurred vision
  • visual impairment
  • pupillary constriction
  • vertigo
  • tinnitus
  • ear discomfort
  • palpitations
  • tachycardia
  • hypertension
  • hypotension
  • dyspnea
  • dry throat
  • increased liver enzymes
  • generalized pruritus
  • sweating
  • urinary disorders
  • erectile dysfunction
  • weakness
  • chest pain
  • emotional abnormality
  • chills
  • chest discomfort
  • lethargy
  • thirst
  • irritability
  • heat sensation
  • weight loss
  • increased serum creatinine
  • anaphylactic response
  • impact on emotional instability
  • delirium
  • suicidal ideation
  • muscle hypertonicity
  • movement disorders
  • serotonin syndrome
  • speech disorders
  • mydriasis
  • orthostatic hypotension
  • hepatitis
  • gait disturbance
  • prolonged prothrombin time
  • fixed rash
  • weakness
  • fever
  • edema
  • rigidity
  • syncope
  • congestive heart failure
  • confusion
  • exacerbation of migraine
  • involuntary muscle contractions
  • exercise-induced dyspnea
  • cough
  • bronchitis
  • urinary retention
  • frequent urination
  • abnormal kidney function tests
  • oliguria
  • increased sweating
  • dysphagia
  • tongue swelling
  • increased salivation
  • progression of rectal cancer
  • progression of esophageal cancer
  • progression of gastric cancer
  • paralyticileus
  • hiccups
  • cholecystitis
  • tinnitus
  • chills
  • buttock pain
  • thigh pain
  • allergic rhinitis
  • epistaxis
  • abnormal vision
  • progression of biliary tract cancer
  • foreign body sensation in the eye
  • progression of liver cancer
  • liver dysfunction
  • nausea
  • dizziness
  • dyspnea
  • confusion
  • migraine
  • speech disorders
  • loss of consciousness
  • recurrence of myocardial infarction
  • hypotension
  • dyspepsia
  • confusion
  • multiple organ failure
  • intentional overdose
  • belching
  • chest discomfort
  • anxiety
  • sweating
  • rigidity
  • pain
  • upper respiratory tract syndrome
  • oral dyskinesia
  • agitation
  • hyperkinesia
  • panic attack
  • hallucinations
  • tinnitus
  • abnormal central nervous system response
  • urticaria
  • rash
  • bronchospasm
  • toxic skin necrosis
  • opioid-induced hyperalgesia
  • withdrawal symptoms
  • respiratory arrest
  • QT prolongation
  • somnolence
  • cardiac arrest
  • death

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a sealed container to prevent air or moisture from entering, and kept in a cool place below room temperature (25 degrees Celsius). Doing so will help maintain the drug's effectiveness over a longer period.

Appearance and packaging

Appearance

Pale yellow oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.